Enzyme immunoassay for flecainide

Clinica Chimica Acta; International Journal of Clinical Chemistry
J P FrecheG Siest

Abstract

In order to develop an enzyme immunoassay (ELISA) for measurement of plasma flecainide levels, we first synthesized flecainide-hemisuccinate-BSA as immunogen. A highly specific antiserum was then raised in rabbits. Enzyme-labelled flecainide was prepared by the mixed anhydride method using hemifumarate-flecainide and horse radish peroxidase. The limit of detection was 10 ng/ml, the method was linear up to 1,000 micrograms/l. The intra and inter-assay variation was 5.1-7.8%. Cross reactivity with various metabolites of flecainide or some chemically related drugs was less than 0.1%. By contrast the cross reaction with some structural analogues achieved 25%. The importance of parts of the aromatic ring structure in immunogenic properties of this drug is discussed.

References

Nov 1, 1989·British Journal of Clinical Pharmacology·A S GrossM Eichelbaum
Dec 1, 1987·Therapeutic Drug Monitoring·R E CoxonG Gallacher
Nov 1, 1969·Archives of Biochemistry and Biophysics·M Steinbuch, R Audran
Aug 27, 1981·The New England Journal of Medicine·J L AndersonB Pitt
May 14, 1982·Journal of Chromatography·J W De JongP P De Tombe
Dec 1, 1981·The American Journal of Cardiology·H J DuffR L Woosley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Related Papers

European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
J BläserH Tschesche
© 2021 Meta ULC. All rights reserved